Arcellx Provides First Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

Related Keywords

Andrea Cohen ,Myesha Lacy ,Kite Pharma Inc ,Exchange Commission ,Drug Administration ,Sam Brown Inc ,Arcellx Inc ,Nasdaq ,Prnewswire Arcellx Inc ,Securities Exchange ,Linkedin ,Rami Elghandour ,Chief Executive ,Kite Pharma ,Fast Track ,Orphan Drug ,Regenerative Medicine Advanced Therapy ,Securities Act ,Securities Exchange Act ,Risk Factors ,Quarterly Report ,Months Ended March ,Arcellx ,Nc ,